Alissa Pharma is a private biotechnology company founded by Stephane Allard, MD; a clinician with vast experience in oncology development.
Alissa Pharma focuses on radioimmunotherapy with novel targeted antibodies for hematology and solid tumors.
Alissa Pharma owns the worldwide rights for Ferritarg™ in all radiopharmaceutical indications. The preclinical dossier is completed.
Alissa Pharma has an experienced management team with a proven track record of obtaining product approvals in both Europe and the US and generating several successful exits. In addition to time, effort, and ownership, the management team has funded all of the expenses since the inception of Alissa Pharma.
Copyright © 2022 Alissa Pharma - All Rights Reserved.